José Luis Casado (J L Casado, José L Casado, Jose L Casado)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 22

Top Topics

Epidermal Growth Factor Receptor

Bone Mineral Density

Hiv Infected Patients

Respiratory Syndrome Coronavirus

Top Venues

International journal of STD & AIDS

Infectious diseases (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

José Luis Casado, Pilar Vizcarra, Adrián Martín-Hondarza, Magdalena Blasco, Marta Grandal-Platero, Johannes Haemmerle, Marina Fernández-Escribano, Alejandro Vallejo
Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination. Viruses 15 (3) (2023)
José Luis Casado, Pilar Vizcarra, Adrián Martín-Hondarza, Magdalena Blasco, Marta Grandal-Platero, Johannes Haemmerle, Marina Fernández-Escribano, Alejandro Vallejo
Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination. Viruses 15 (3) (2023)
Cristina Saavedra, Alejandro Vallejo, Federico Longo, Juan José Serrano, María Fernández, María Gion, Elena López-Miranda, Noelia Martínez-Jáñez, Eva Guerra, Jesús Chamorro, Diana Rosero, Héctor Velasco, Adrián Martín, Alfredo Carrato, José Luis Casado, Cortes Salgado Alfonso
Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors. Cancers 15 (7) (2023)
José Luis Casado, Pilar Vizcarra, Adrián Martín-Hondarza, Magdalena Blasco, Marta Grandal-Platero, Johannes Haemmerle, Marina Fernández-Escribano, Alejandro Vallejo
Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination. Viruses 15 (3) (2023)
José Luis Casado, Johannes Haemmerle, Pilar Vizcarra, Gema Ramirez-Alonso, Andrea Salazar-Tosco, Beatriz Romero-Hernandez, Magdalena Blasco, Mario Rodriguez-Dominguez, Itria G Mirabella, Alejandro Vallejo, Marina Fernandez-Escribano
Risk of SARS-CoV-2 Reinfections in a Prospective Inception Cohort Study: Impact of COVID-19 Vaccination. Journal of clinical medicine 11 (12) (2022)
María Abad-Fernández, Francisco J Hernández-Walias, María J Ruiz de León, María J Vivancos, María J Pérez-Elías, Ana Moreno, José Luis Casado, Carmen Quereda, Fernando Dronda, Santiago Moreno, Alejandro Vallejo
HTLV-2 Enhances CD8 + T Cell-Mediated HIV-1 Inhibition and Reduces HIV-1 Integrated Proviral Load in People Living with HIV-1. Viruses 14 (11) (2022)
José Luis Casado, Pilar Vizcarra, María J Vivancos, Javier Martinez-Sanz, María J Perez-Elías, Ana Moreno, Alejandro Vallejo
Low risk of bacterial co-infection, opportunistic diseases, and persistent immunosuppression in people living with HIV and COVID-19. Infection 50 (4) (2022)
Pilar Vizcarra, Marta Rosillo, José M Del Rey, Ana Moreno, María J Vivancos, José Luis Casado
Unravelling hip-spine bone mineral density discordance in people living with HIV. Journal of bone and mineral metabolism 40 (6) (2022)
José Luis Casado, Pilar Vizcarra, Hector Velasco, Johannes Hammerle, Amaranta McGee, Marina Fernandez-Escribano, Alejandro Vallejo
Progressive and Parallel Decline of Humoral and T-Cell Immunity in Convalescent Healthcare Workers with Asymptomatic or Mild-to-Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection. The Journal of infectious diseases 224 (2) (2021)
José Luis Casado, Johannes Haemmerle, Pilar Vizcarra, Mario Rodriguez-Dominguez, Tamara Velasco, Hector Velasco, Elena Centenera, Beatriz Romero-Hernandez, Marina Fernandez-Escribano, Alejandro Vallejo
T-cell response after first dose of BNT162b2 SARS-CoV-2 vaccine among healthcare workers with previous infection or cross-reactive immunity. Clinical & translational immunology 10 (9) (2021)
Maria Jose Fuster-RuizdeApodaca, Noé Garin, Ángeles Jaén, José Luis Casado, Lorna Leal, Santiago Cenoz, María José Fuster-Ruiz de Apodaca
Recreational Drug Use in People Living with HIV in Spain: Factors Associated with Drug Use and the Impact on Clinical Outcomes. AIDS and behavior 25 (12) (2021)
Jorge Díaz-Álvarez, Patricia Roiz, Luis Gorospe, Ana Ayala, Sergio Pérez-Pinto, Javier Martínez-Sanz, Matilde Sánchez-Conde, José Luis Casado, María J Pérez-Elías, Ana Moreno, Raquel Ron, María J Vivancos, Pilar Vizcarra, Santiago Moreno, Sergio Serrano-Villar
Implementation of a lung cancer screening initiative in HIV-infected subjects. PloS one 16 (12) (2021)
José Luis Casado, Elisa Moraga, Pilar Vizcarra, Héctor Velasco, Adrián Martín-Hondarza, Johannes Haemmerle, Sandra Gómez, Carmen Quereda, Alejandro Vallejo
Expansion of CD56 dim CD16 neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients. Viruses 14 (1) (2021)
Pilar Vizcarra, Juan Gallego, María J Vivancos, Walter A Sifuentes, María Llop, José Luis Casado
Evaluation of the fracture risk assessment tool for determining bone disease and the impact of secondary causes of osteoporosis in people living with HIV. HIV research & clinical practice 21 (2-3) (2020)
Christian Hoffmann, José Luis Casado, Georg Härter, Pilar Vizcarra, Ana Moreno, Dario Cattaneo, Paola Meraviglia, Christoph D Spinner, Farhad Schabaz, Stephan Grunwald, Cristina Gervasoni
Immune deficiency is a risk factor for severe COVID-19 in people living with HIV. HIV medicine 22 (5) (2020)
José Luis Casado, Pilar Vizcarra, José L Blanco, Rocío Montejano, Eugenia Negredo, Nuria Espinosa, Marta Montero, Alvaro Mena, Rosario Palacios, Juan C Lopez, Jorge Vergas, Maria J Galindo, Alfonso Cabello, Miguel García Deltoro, Alberto Diaz De Santiago, null null
Maintenance of virologic suppression and improvement in comorbidities after simplification to raltegravir plus boosted darunavir among treatment-experienced HIV-infected patients. International journal of STD & AIDS 31 (5) (2020)
José Luis Casado, Marta Monsalvo, María Fontecha, Pilar Vizcarra, Miguel A Rodriguez, María Jesús Vivancos, Santiago Moreno
Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting. HIV research & clinical practice 20 (2) (2019)
Pilar Vizcarra, José L Blanco, Rocío Montejano, Eugenia Negredo, Nuria Espinosa, José Luis Casado, null null
Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy. Infectious diseases (London, England) 52 (3) (2019)
Marta Monsalvo, Alejandro Vallejo, María Fontecha, María J Vivancos, Pilar Vizcarra, José Luis Casado
CD4/CD8 ratio improvement in HIV-1-infected patients receiving dual antiretroviral treatment. International journal of STD & AIDS 30 (7) (2019)
José Luis Casado, M Monsalvo, Pilar Vizcarra, M Fontecha, S Serrano-Villar, Santiago Moreno
Evaluation of kidney function in HIV-infected patients receiving an antiretroviral regimen containing one or two inhibitors of the tubular secretion of creatinine. HIV medicine 20 (10) (2019)
María Fontecha, Marta Monsalvo, Miguel A Rodriguez-Sagrado, María J Vivancos, Ana Moreno, José Luis Casado
Long-term improvement in renal, bone, lipid parameters, and CD4/CD8 ratio in HIV-infected patients switching to a dual therapy with lamivudine plus boosted darunavir. Infectious diseases (London, England) 51 (4) (2019)
José Luis Casado, C Santiuste, M J Vivancos, M Monsalvo, A Moreno, M J Perez-Elías, J M Del Rey, S Moreno
Switching to abacavir versus use of a nucleoside-sparing dual regimen for HIV-infected patients with tenofovir-associated renal toxicity. HIV medicine (2018)